| Application no. and date | 18795807.9 (espacenet) (Federated) (European Patent Register), 20181004 | | Patent/reg. no. and date | DK/EP 3694863, 20230621 | | Publication date | 20200819 | | Priority no. and date | US 201762570326 P, 20171010, US 201862727734 P, 20180906 | | EP pub. no. and date |
EP 3694863 20200819 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V461198DK00 | | Inventor | BOWLES, Paul, 452 Raymond Hill Road
Uncasville
Connecticut 06382, US,
ROSE, Peter Robert, 34 Silas Deane Road
Ledyard
Connecticut 06339, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/439 (2006.01) , A61P 35/00 (2006.01) , C07D 498/18 (2006.01) | | Title | Krystallinsk form af frit basehydrat af lorlatinib | | Int. application no. | IB2018057735 | | Int. publication no. | WO2019073347 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
